Gene · 619554
Papers2,728
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,728
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application. | Int J Mol Sci | 2022 | 36614057 | PubTator, text mining | PubMed |
| Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer. | Int J Mol Sci | 2022 | 36613487 | PubTator, text mining | PubMed |
| Does the Choice of Anaesthesia Affect Cancer? A Molecular Crosstalk between Theory and Practice. | Cancers (Basel) | 2022 | 36612205 | PubTator, text mining | PubMed |
| An Overview of 10th Anniversary of Cells-Advances in Cell Nuclei: Function, Transport and Receptors. | Cells | 2022 | 36611849 | PubTator, text mining | PubMed |
| Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer. | Front Oncol | 2022 | 36591507 | PubTator, text mining | PubMed |
| Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration. | Chin Med J (Engl) | 2022 | 36583914 | PubTator, text mining | PubMed |
| Bioinformatics and System Biology Techniques to Determine Biomolecular Signatures and Pathways of Prion Disorder. | Bioinform Biol Insights | 2022 | 36582393 | PubTator, text mining | PubMed |
| Anticancer activity of glycoalkaloids from Solanum plants: A review. | Front Pharmacol | 2022 | 36569285 | PubTator, text mining | PubMed |
| MicroRNA Modulation during Orthodontic Tooth Movement: A Promising Strategy for Novel Diagnostic and Personalized Therapeutic Interventions. | Int J Mol Sci | 2022 | 36555142 | PubTator, text mining | PubMed |
| Current Insights and Progress in the Clinical Management of Head and Neck Cancer. | Cancers (Basel) | 2022 | 36551565 | PubTator, text mining | PubMed |
| Construction of a novel miRNA regulatory network and identification of target genes in gestational diabetes mellitus by integrated analysis. | Front Genet | 2022 | 36544488 | PubTator, text mining | PubMed |
| Distinct non-coding RNA cargo of extracellular vesicles from M1 and M2 human primary macrophages. | J Extracell Vesicles | 2022 | 36544271 | PubTator, text mining | PubMed |
| Role of m6A modification and novel circ_0066715/ miR-486-5p/ ETS1 axis in rheumatoid arthritis macrophage polarization progression. | Aging (Albany NY) | 2022 | 36541909 | PubTator, text mining | PubMed |
| MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma. | Technol Cancer Res Treat | 2022 | 36537076 | PubTator, text mining | PubMed |
| The new ceRNA crosstalk between mRNAs and miRNAs in intervertebral disc degeneration. | Front Cell Dev Biol | 2022 | 36531954 | PubTator, text mining | PubMed |
| Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data. | Front Endocrinol (Lausanne) | 2022 | 36523593 | PubTator, text mining | PubMed |
| MicroRNAs: a crossroad that connects obesity to immunity and aging. | Immun Ageing | 2022 | 36517853 | PubTator, text mining | PubMed |
| Establishment of preanalytical conditions for microRNA profile analysis of clinical plasma samples. | PLoS One | 2022 | 36516194 | PubTator, text mining | PubMed |
| circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36514216 | PubTator, text mining | PubMed |
| Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes. | Front Pharmacol | 2022 | 36506555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/619554/papers?page=19